Douglas G. Cole Denali Therapeutics Inc. (DNLI) insider trading activity

DNLI Quotes by TradingView

Douglas G. Cole is Director of Denali Therapeutics Inc.. Currently has a direct ownership of 26,564 shares of DNLI, which is worth approximately $575,110. The most recent transaction as insider was on Jun 01, 2023, when has been sold 4,216 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 26.6K
0% 3M change
0% 12M change
Total Value Held $575,110

Douglas G. Cole Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 01 2023
BUY
Grant, award, or other acquisition
-
4,216 Added 13.7%
26,564 Common Stock
Jun 02 2022
BUY
Grant, award, or other acquisition
-
5,986 Added 21.13%
22,348 Common Stock
Jun 02 2021
BUY
Grant, award, or other acquisition
-
2,074 Added 28.02%
5,327 Common Stock
Jun 01 2021
BUY
Exercise of conversion of derivative security
-
3,253 Added 50.0%
3,253 Common Stock

Also insider at

SANA
Sana Biotechnology, Inc. Healthcare
SGTX
Sigilon Therapeutics, Inc. Healthcare
FHTX
Foghorn Therapeutics Inc. Healthcare
DGC

Douglas G. Cole

Director
Cambridge, MA

Track Institutional and Insider Activities on DNLI

Follow Denali Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DNLI shares.

Notify only if

Insider Trading

Get notified when an Denali Therapeutics Inc. insider buys or sells DNLI shares.

Notify only if

News

Receive news related to Denali Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DNLI